Megestrol Acetate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

23 API Suppliers, 14 USDMF, 8 CEP/COS, 3 KDMF, 6 NDC API, 10 Listed Suppliers, $ API Reference Price

INTERMEDIATES

1 Intermediates Suppliers

1 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

59 FDF Dossiers, 21 FDA Orange Book, 19 Europe, 2 Canada, 17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION;ORAL - 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUSPENSION;ORAL - 125MG/ML

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 4 SPI Pharma, 2 Seqens, 4 DKSH, 1 Pharm-RX Chemical, 4 Faran Shimi Pharmaceutical, 11 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 10 Actylis, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 18 BASF, 11 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 10 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 35 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 15 Roquette, 13 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

62 Fillers, Diluents & Binders, 44 Coating Systems & Additives, 31 Thickeners and Stabilizers, 30 Direct Compression, 27 Controlled & Modified Release, 24 Solubilizers, 20 Disintegrants & Superdisintegrants, 18 Granulation, 18 Topical, 15 Parenteral, 15 Co-Processed Excipients, 14 Lubricants & Glidants, 11 Film Formers & Plasticizers, 11 Emulsifying Agents, 10 Taste Masking, 9 API Stability Enhancers, 8 Rheology Modifiers, 6 Chewable & Orodispersible Aids, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 2 Coloring Agents

DIGITAL CONTENT

9 NEWS #PharmaBuzz

9 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 22 Finished Drug Prices

MARKET PLACE

5 APIs, 4 FDF Dossiers

PATENTS & EXCLUSIVITIES

5 US Patents

5 US Patents

REF. STANDARDS & IMPURITIES

6 EDQM, 4 USP, 7 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 20264 / DOSAGE - SUSPENSION;ORAL - 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
MEGESTROL ACETATE(UNII: TJ2M0FR8ES) (MEGESTROL - UNII:EA6LD1M70M)	MEGESTROL ACETATE	40mg in 1

Inactive Ingredients

Ingredient Name	E.R. Squibb & Sons, L.L.C.
ALCOHOL(3K9958V90M)
CITRIC ACID MONOHYDRATE(2968PHW8QP)
POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A)
POLYSORBATE 80(6OZP39ZG8H)
SODIUM BENZOATE(OJ245FE5EU)
SODIUM CITRATE, UNSPECIFIED FORM(1Q73Q2JULR)
SUCROSE(C151H8M554)
WATER(059QF0KO0R)
XANTHAN GUM(TTV12P4NEE)

Drug Product Composition: Megestrol Acetate